Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 17: 316-325, 2004. First published March 30, 2004; doi:10.1152/physiolgenomics.00211.2003
1094-8341/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/3/316    most recent
00211.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barisani, D.
Right arrow Articles by Weiss, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barisani, D.
Right arrow Articles by Weiss, G.
Received 15 December 2003; accepted in final form 16 March 2004.
Physiological Genomics 17:316-325 (2004)
1094-8341/04 $5.00 © 2004 American Physiological Society

Adaptive changes of duodenal iron transport proteins in celiac disease

Donatella Barisani1, Antonina Parafioriti2, Maria Teresa Bardella3, Heinz Zoller4, Dario Conte3, Elisabetta Armiraglio2, Cristina Trovato3, Robert O. Koch4 and Günter Weiss4

1 Department of Experimental and Environmental Medicine and Medical Biotechnology, University of Milano-Bicocca, 20052 Monza, Italy
2 Department of Pathology, Istituto Ortopedico Gaetano Pini, 20122 Milan, Italy
3 Department of Medical Sciences, IRCCS Ospedale Maggiore, 20122 Milan, Italy
4 Department of Internal Medicine, University of Innsbruck, A6020 Innsbruck, Austria

Iron deficiency is a manifestation of celiac disease (CD) usually attributed to a decreased absorptive surface, although no data on the regulation of iron transport under these conditions are currently available. Our aim was to evaluate divalent metal transporter 1 (DMT1), duodenal cytochrome b (Dcytb), ferroportin 1 (FP1), hephaestin, and transferrin receptor 1 (TfR1) expression, as well as iron regulatory protein (IRP) activity in duodenal biopsies from control, anemic, and CD patients. We studied 10 subjects with dyspepsia, 6 with iron-deficiency anemia, and 25 with CD. mRNA levels were determined by real-time PCR, protein expression by Western blotting or immunohistochemistry, and IRP activity by gel shift assay. Our results showed that DMT1, FP1, hephaestin, and TfR1 mRNA levels were significantly increased in CD patients with reduced body iron stores compared with controls, similar to what was observed in anemic patients. Protein expression paralleled the mRNAs changes. DMT1 protein expression was localized in differentiated enterocytes at the villi tips in controls, whereas with iron deficiency it was observed throughout the villi. FP1 expression was localized on the basolateral membrane of enterocytes and increased with low iron stores. TfR1 was localized in the crypts in controls but also in the villi with iron deficiency. These changes were paralleled by IRP activity, which increased in all iron-deficient subjects. We conclude that duodenal DMT1, FP1, hephaestin, and TfR1 expression and IRP activity, thus the iron absorption capacity, are upregulated in CD patients as a consequence of iron deficiency, whereas the increased enterocyte proliferation observed in CD has no effect on iron uptake regulation.

divalent metal transporter 1; transferrin receptor 1; ferroportin 1; iron absorption




This article has been cited by other articles:


Home page
haematolHome page
G. Bergamaschi, K. Markopoulos, R. Albertini, A. Di Sabatino, F. Biagi, R. Ciccocioppo, E. Arbustini, and G. R. Corazza
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease
Haematologica, December 1, 2008; 93(12): 1785 - 1791.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Matysiak-Budnik, I. C. Moura, M. Arcos-Fajardo, C. Lebreton, S. Menard, C. Candalh, K. Ben-Khalifa, C. Dugave, H. Tamouza, G. van Niel, et al.
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease
J. Exp. Med., January 21, 2008; 205(1): 143 - 154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.